Sayer Al-harbi - Concepedia

Author

Sayer Al-harbi

King Faisal Specialist Hospital & Research Centre

Also Known As

Al-Harbi, Sayer, S Al-Harbi, S Al-harbi, S. Al Harbi, S. Al-Harbi, S. Al-harbi, Sameer Mubayrik Alharbi, Sayer Al-Harbi, Sayer Al-harbi, Sayer Alharbi

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

King Faisal Specialist Hospital & Research Centre Cleveland Clinic Case Western Reserve University Cleveland State University Cleveland Clinic Lerner College of Medicine

About

Sayer Al-harbi is an author at King Faisal Specialist Hospital & Research Centre specializing in medicine, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	664
2	Immunology	3	3	571
3	Cell Biology	2	2	473
4	Pathology	2	2	191
5	Cancer Genetics	1	1	93

Sayer Al-harbi

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies Gaurav S. Choudhary, Sayer Al-harbi, Suparna Mazumder, Cell Death and Disease ImmunologyMtor PathwaysImmunotherapyBcl-2 Inhibitor Abt-199Tumor Biology	2015	356
Clinicopathological Analysis of Papillary Thyroid Cancer with<i>PIK3CA</i>Alterations in a Middle Eastern Population Jehad Abubaker, Zeenath Jehan, Prashant Bavi, The Journal of Clinical Endocrinology & Metabolism	2007	168
Mcl-1 Phosphorylation Defines ABT-737 Resistance That Can Be Overcome by Increased NOXA Expression in Leukemic B cells Suparna Mazumder, Gaurav S. Choudhary, Sayer Al-harbi, Cancer Research Noxa ExpressionMixed-phenotype Acute LeukemiaImmunologyCell DeathCancer Biology	2012	117
Herbal melanin modulates tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production Adila El‐Obeid, Sayer Al-harbi, Naif A. Al-Jomah, Phytomedicine InflammationHerbal MedicineImmunologyPathologyPhytopharmacology	2005	98
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population Jehad Abubaker, Prashant Bavi, Sayer Al-harbi, Oncogene Colorectal CancersMedicinePathologyColorectal CancerPik3ca Mutations	2008	93
Prognostic significance of alterations in KRAS isoforms KRAS‐4A/4B and <i>KRAS</i> mutations in colorectal carcinoma Jehad Abubaker, Prashant Bavi, Wael Al‐Haqawi, The Journal of Pathology	2009	85
An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737 Sayer Al-harbi, Brian T. Hill, Suparna Mazumder, Blood	2011	84
miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies Sayer Al-harbi, Gaurav S. Choudhary, Jey Sabith Ebron, Molecular Cancer	2015	49

Page 1